Strategic Market Position Aurora Europe is one of the largest authorized importers and distributors of medical cannabis in Europe, indicating significant market reach and opportunities for supply chain expansion or partnership offerings.

European Expansion Since entering the German market in 2015 and acquiring Pedanios in 2017, Aurora Europe has established a strong foothold in European medical cannabis distribution, presenting ongoing sales potential within regulatory-compliant channels.

Quality and Compliance Focus Operating numerous EU GMP-certified facilities, Aurora emphasizes high-quality, regulated medical cannabis products, creating opportunities for suppliers and technology providers specializing in compliance and quality assurance.

Industry Collaboration Active participation in industry events like CB Expo demonstrates Aurora's engagement with key stakeholders, providing networking avenues to introduce complementary products, services, or technology solutions.

Moderate Revenue Scale With revenue estimated between 1 million to 10 million dollars, Aurora Europe offers a growth-oriented customer profile suitable for customized solutions, strategic partnerships, and value-added services in the medical cannabis sector.